Trial: 201802152

Pevonedistat in Combination with Ruxolitinib for Treatment of Patients with Myelofibrosis

Phase

I

Principal Investigator

Oh, Stephen

Disease Site

Myeloproliferative Disease; Other Hematopoietic

Learn more about this study at: clinicaltrials.gov